These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

49 related articles for article (PubMed ID: 8771006)

  • 1. Bone disease in patients receiving growth hormone.
    Watkins SL
    Kidney Int Suppl; 1996 Jan; 53():S126-7. PubMed ID: 8771006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is severe renal osteodystrophy a contraindication for recombinant human growth hormone treatment?
    Watkins SL
    Pediatr Nephrol; 1996 Jun; 10(3):351-4. PubMed ID: 8792404
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does renal osteodystrophy develop and/or progress during the course of rhGH treatment?
    Watkins SL
    Br J Clin Pract Suppl; 1996 Aug; 85():59-60. PubMed ID: 8995035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Growth and renal function].
    Antoniazzi F; Mengarda F; Lauriola S; Serra A; Zamboni G; Tatò L
    Pediatr Med Chir; 1997; 19(5):341-7. PubMed ID: 9493225
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Serum osteocalcin in children with chronic renal insufficiency].
    Peco-Antić A; Nastić-Mirić D; Milikić V; Babić D; Pejcić I; Kostić M; Paripović V; Jovanović O; Kruscić D; Mancić J
    Srp Arh Celok Lek; 1996; 124(9-10):227-31. PubMed ID: 9102853
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Derangements of the somatotropic hormone axis in chronic renal failure.
    Tönshoff B; Blum WF; Mehls O
    Kidney Int Suppl; 1997 Mar; 58():S106-13. PubMed ID: 9067957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Growth retardation in children with chronic renal failure.
    Kuizon BD; Salusky IB
    J Bone Miner Res; 1999 Oct; 14(10):1680-90. PubMed ID: 10491215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Daily or intermittent calcitriol administration during growth hormone therapy in rats with renal failure and advanced secondary hyperparathyroidism.
    Sanchez CP; He YZ
    J Am Soc Nephrol; 2005 Apr; 16(4):929-38. PubMed ID: 15728789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Headache, idiopathic intracranial hypertension and slipped capital femoral epiphysis during growth hormone treatment: a safety update from the KIGS database.
    Darendeliler F; Karagiannis G; Wilton P
    Horm Res; 2007; 68 Suppl 5():41-7. PubMed ID: 18174706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipids, blood pressure and bone metabolism after growth hormone therapy in elderly hemodialysis patients.
    Viidas U; Johannsson G; Mattson-Hultén L; Ahlmén J
    J Nephrol; 2003; 16(2):231-7. PubMed ID: 12768070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A placebo-controlled, double-blind trial of growth hormone treatment in prepubertal children after renal transplant.
    Hokken-Koelega AC; Stijnen T; de Jong RC; Donckerwolcke RA; Groothoff JW; Wolff ED; Blum WF; de Muinck Keizer-Schrama SM; Drop SL
    Kidney Int Suppl; 1996 Jan; 53():S128-34. PubMed ID: 8771007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effects of growth hormone (GH) on bone mineral status and bone turnover markers in patients with isolated GH deficiency and multiple pituitary hormone deficiency.
    Gonc EN; Kandemir N
    Clin Endocrinol (Oxf); 2007 May; 66(5):672-7. PubMed ID: 17381489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
    Iglesias P; Díez JJ; Fernández-Reyes MJ; Méndez J; Bajo MA; Aguilera A; Selgas R
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):741-9. PubMed ID: 15163339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcitropic hormonal status in north Indian patients with end-stage renal disease.
    Singh AK; Avula S; Kher V; Rao DS; Mithal A
    Natl Med J India; 1999; 12(5):202-7. PubMed ID: 10612998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Administration of ghrelin to young uraemic rats increases food intake transiently, stimulates growth hormone secretion and does not improve longitudinal growth.
    Alvarez-García O; García-López E; Rodríguez J; Gil-Peña H; Molinos I; Carbajo-Pérez E; Santos F
    Nephrol Dial Transplant; 2007 May; 22(5):1309-13. PubMed ID: 17317714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nail disorders in patients with chronic renal failure and undergoing haemodialysis treatment: a case-control study.
    Dyachenko P; Monselise A; Shustak A; Ziv M; Rozenman D
    J Eur Acad Dermatol Venereol; 2007 Mar; 21(3):340-4. PubMed ID: 17309455
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Testing for growth hormone release is not necessary prior to treatment of children with chronic renal insufficiency with recombinant human growth hormone.
    Kohaut EC; Fine RN
    Kidney Int Suppl; 1996 Jan; 53():S119-22. PubMed ID: 8771004
    [No Abstract]   [Full Text] [Related]  

  • 19. Impact of etiology of chronic renal failure on growth in children.
    Sultana S; Rahman MH; Paul SK; Hossain MM
    Mymensingh Med J; 2007 Jul; 16(2 Suppl):S34-39. PubMed ID: 17917629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Growth hormone stimulation tests in chronic renal failure with metabolic acidosis.
    Bircan Z; Kervancioğlu M; Soran M; Yildirim I
    Acta Paediatr Jpn; 1998 Feb; 40(1):70-2. PubMed ID: 9583205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.